PharmaNet Development Group Inc (PDGI) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 104 transactions totaling $4.5M, demonstrating a bearish sentiment with -$4.0M in net insider flow. The most recent transaction on Mar 20, 2009 involved a transaction of 45,396 shares valued at $227.0K.
No significant insider buying has been recorded for PDGI in the recent period.
No significant insider selling has been recorded for PDGI in the recent period.
Based on recent SEC filings, insider sentiment for PDGI is bearish with an Insider Alignment Score of 5/100 and a net flow of -$4.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at PharmaNet Development Group Inc (PDGI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading PDGI stock, having executed 104 transactions in the past 90 days. The most active insider is Jack Levine (Executive), who has made 14 transactions totaling $2.7M.
Get notified when executives and directors at PDGI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 20, 2009 | P. Hamill John | Executive | Tender | 45,396 | $5.00 | $227.0K | |
| Mar 20, 2009 | Joseph Newman Thomas | Executive | Tender | 54,463 | $5.00 | $272.3K | |
| Mar 20, 2009 | Golieb Arnold | Executive | Tender | 25,971 | $5.00 | $129.9K | |
| Mar 20, 2009 | Golieb Arnold | Executive | Tender | 800 | $5.00 | $4.0K | |
| Mar 20, 2009 | G. Tombros Peter | Executive | Tender | 21,377 | $5.00 | $106.9K | |
| Mar 20, 2009 | A. Classon Rolf | Executive | Tender | 16,502 | $5.00 | $82.5K | |
| Mar 20, 2009 | Mark Di Ianni | Executive | Tender | 19,315 | $5.00 | $96.6K | |
| Mar 20, 2009 | P. Mcmullen Jeffrey | Executive | Tender | 143,651 | $5.00 | $718.3K | Large |
| Mar 20, 2009 | R. Elias Lewis | Executive | Tender | 20,424 | $5.00 | $102.1K | |
| Mar 20, 2009 | Per Wold Olsen | Executive | Tender | 19,998 | $5.00 | $100.0K | |
| Mar 20, 2009 | Cashen Sheldrick Robin | Executive | Tender | 16,612 | $5.00 | $83.1K | |
| Mar 20, 2009 | M. Olivier David | Executive | Tender | 14,998 | $5.00 | $75.0K | |
| Jun 4, 2008 | Per Wold Olsen | Executive | Award | 7,654 | $16.33 | $125.0K | |
| Jun 4, 2008 | G. Tombros Peter | Executive | Award | 11,481 | $16.33 | $187.5K | |
| Jun 4, 2008 | Golieb Arnold | Executive | Award | 7,654 | $16.33 | $125.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 35 | $4.2M | 32.8% |
Award(A) | 33 | $4.1M | 32.1% |
Exercise(M) | 14 | $2.2M | 17.4% |
Tender(U) | 12 | $2.0M | 15.5% |
Purchase(P) | 6 | $220.1K | 1.7% |
Disposition(D) | 4 | $67.1K | 0.5% |
Insider selling pressure at PharmaNet Development Group Inc has increased, with 16 insiders executing 104 transactions across all time. Total sales of $4.2M significantly outpace purchases of $220.1K, resulting in a net outflow of $4.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.